-
Spatial genome organization in the formation of chromosomal translocations.
Semin Cancer Biol. 2007 Feb;17(1):80-90
PMID: 17137790
-
CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.
Blood. 2000 Dec 1;96(12):3681-95
PMID: 11090048
-
The oncogenic fusion protein nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) induces two distinct malignant phenotypes in a murine retroviral transplantation model.
Oncogene. 2003 Jul 24;22(30):4642-7
PMID: 12879008
-
Myc dynamically and preferentially relocates to a transcription factory occupied by Igh.
PLoS Biol. 2007 Aug;5(8):e192
PMID: 17622196
-
Aberrant expression of Fra-2 promotes CCR4 expression and cell proliferation in adult T-cell leukemia.
Oncogene. 2008 May 22;27(23):3221-32
PMID: 18071306
-
Active genes dynamically colocalize to shared sites of ongoing transcription.
Nat Genet. 2004 Oct;36(10):1065-71
PMID: 15361872
-
Transforming potential of the c-fms proto-oncogene (CSF-1 receptor).
Nature. 1987 Feb 5-11;325(6104):549-52
PMID: 3027579
-
The anaplastic lymphoma kinase in the pathogenesis of cancer.
Nat Rev Cancer. 2008 Jan;8(1):11-23
PMID: 18097461
-
Lymphoma- and leukemia-associated chromosomal translocations in healthy individuals.
Genes Chromosomes Cancer. 2003 Mar;36(3):211-23
PMID: 12557221
-
Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma.
Cancer Res. 2003 Mar 15;63(6):1179-82
PMID: 12649172
-
An oncogene-induced DNA damage model for cancer development.
Science. 2008 Mar 7;319(5868):1352-5
PMID: 18323444
-
Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis.
Oncogene. 2001 Apr 30;20(19):2453-64
PMID: 11402340
-
Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells.
Science. 2000 Oct 6;290(5489):138-41
PMID: 11021799
-
Spatial proximity of translocation-prone gene loci in human lymphomas.
Nat Genet. 2003 Jul;34(3):287-91
PMID: 12808455
-
The impact of translocations and gene fusions on cancer causation.
Nat Rev Cancer. 2007 Apr;7(4):233-45
PMID: 17361217
-
B and CTL responses to the ALK protein in patients with ALK-positive ALCL.
Int J Cancer. 2006 Feb 1;118(3):688-95
PMID: 16114011
-
The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas.
Cancer. 2008 Feb 1;112(3):552-61
PMID: 18085637
-
Id family of helix-loop-helix proteins in cancer.
Nat Rev Cancer. 2005 Aug;5(8):603-14
PMID: 16034366
-
c-Jun is a JNK-independent coactivator of the PU.1 transcription factor.
J Biol Chem. 1999 Feb 19;274(8):4939-46
PMID: 9988737
-
Locus-specific and activity-independent gene repositioning during early tumorigenesis.
J Cell Biol. 2008 Jan 14;180(1):39-50
PMID: 18195100
-
JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells.
Cell. 2004 Oct 29;119(3):431-43
PMID: 15507213
-
Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3), which promotes viability of Hodgkin/Reed-Sternberg cells.
Blood. 2006 Mar 15;107(6):2536-9
PMID: 16263788
-
Macrophage lineage switching of murine early pre-B lymphoid cells expressing transduced fms genes.
Mol Cell Biol. 1990 Jun;10(6):2703-14
PMID: 2160584
-
Launching the T-cell-lineage developmental programme.
Nat Rev Immunol. 2008 Jan;8(1):9-21
PMID: 18097446
-
Characterization of t(2;5) reciprocal transcripts and genomic breakpoints in CD30+ cutaneous lymphoproliferations.
Blood. 1998 Jun 15;91(12):4668-76
PMID: 9616164
-
Promoter specificity and biological activity of tethered AP-1 dimers.
Mol Cell Biol. 2002 Jul;22(13):4952-64
PMID: 12052899
-
Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas.
Blood. 2003 Feb 15;101(4):1513-9
PMID: 12393503
-
The nuclear topography of ABL, BCR, PML, and RARalpha genes: evidence for gene proximity in specific phases of the cell cycle and stages of hematopoietic differentiation.
Blood. 1999 Feb 15;93(4):1197-207
PMID: 9949162
-
Increased recombination between active tRNA genes.
DNA Cell Biol. 2006 Jun;25(6):359-64
PMID: 16792506
-
Positional stability of single double-strand breaks in mammalian cells.
Nat Cell Biol. 2007 Jun;9(6):675-82
PMID: 17486118
-
Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma.
Nat Immunol. 2006 Feb;7(2):207-15
PMID: 16369535
-
Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B.
EMBO J. 2002 Aug 1;21(15):4104-13
PMID: 12145210
-
E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas.
Mol Cell Biol. 1997 Aug;17(8):4782-91
PMID: 9234734
-
Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules or molecules of proximal T-cell receptor signaling.
Blood. 2004 Nov 15;104(10):3358-60
PMID: 15297316
-
WHO-EORTC classification for cutaneous lymphomas.
Blood. 2005 May 15;105(10):3768-85
PMID: 15692063
-
Functional organisation of the genome during interphase.
Curr Opin Genet Dev. 2007 Oct;17(5):451-5
PMID: 17920259
-
Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas.
Blood. 2005 Dec 15;106(13):4287-93
PMID: 16123212
-
Effect of all-trans-retinoic acid on c-fms proto-oncogene [colony-stimulating factor 1 (CSF-1) receptor] expression and CSF-1-induced invasion and anchorage-independent growth of human breast carcinoma cells.
Cancer Res. 1999 Nov 1;59(21):5578-85
PMID: 10554038
-
Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis.
Br J Haematol. 2007 May;137(4):342-8
PMID: 17456056
-
Dynamics of DNA double-strand breaks revealed by clustering of damaged chromosome domains.
Science. 2004 Jan 2;303(5654):92-5
PMID: 14704429
-
Three children with CD30 cutaneous anaplastic large cell lymphomas bearing the t(2;5)(p23;q35) translocation.
Pediatr Dermatol. 2004 May-Jun;21(3):212-7
PMID: 15165197